Evidence map›Paper›PMID 37476066›Full record

ArticleBioengineering & translational medicine2023

Plasma-activated medium triggers immunomodulation and autophagic activity for periodontal regeneration.

Shengfang Wang, Peiyu Wang, Rik Thompson, Kostya Ostrikov, Yin Xiao, Yinghong Zhou

Open access · goldAbstract read
In one paragraph

Article in Bioengineering & translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Shengfang WangCentre for Biomedical Technologies Queensland University of Technology Brisbane Queensland Australia.
Peiyu WangSchool of Biomedical Sciences Queensland University of Technology Brisbane Queensland Australia.ORCID https://orcid.org/0000-0002-6455-5043
Rik ThompsonSchool of Biomedical Sciences Queensland University of Technology Brisbane Queensland Australia.
Kostya OstrikovCentre for Biomedical Technologies Queensland University of Technology Brisbane Queensland Australia.
Yin XiaoSchool of Medicine and Dentistry Griffith University Gold Coast Queensland Australia.
Yinghong ZhouSchool of Dentistry, Faculty of Health and Behavioural Sciences The University of Queensland Brisbane Queensland Australia.ORCID https://orcid.org/0000-0001-9757-7735
Queensland University of Technology · AUTranslational Research Institute · AUGriffith University · AUThe University of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Periodontitis is an infection-induced inflammation, evidenced by an increase in inflammatory macrophage infiltration. Recent research has highlighted the role of plasma-activated medium (PAM) as a regulator of the innate immune system, where macrophages are the main effector cells. This study therefore aims to investigate the immunomodulatory effects of PAM on macrophages and its potential applications for periodontitis management. PAM was generated using an argon jet and applied to culture macrophages. Proinflammatory macrophage markers were significantly reduced after PAM stimulation, and this was correlated with the activation of autophagy via the Akt signaling pathway. Further investigations on the proregenerative effects of PAM-treated macrophages on periodontal ligament cells (PDLCs) revealed a significant increase in the expression of osteogeneis/cementogenesis-associated markers as well as mineralization nodule formation. Our findings suggest that PAM is an excellent candidate for periodontal therapeutic applications.

Indexed as

autophagic activityimmunoregulationperiodontal regenerationplasma‐activated medium (PAM)

Identifiers

PMID37476066
PMCPMC10354773
OpenAlexW4379506024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.